merged_document_6

SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANIES

Sumer Internship Program Project Repot 2014-16

Prepared By -Dharmik D Bhatt Submitted To Gujarat Technical University

Company - WellCare LifeScience

308 Abhushan Complex, Near Kalupur Bank, Opp SVC Bank Stadium Road, Navarangpura, Ahmedabad

College – Oakbrook Business School

Plot No. 225, Opp Maharaj Hotel lane, Jamiyatpura Road, S.G Highway, Gandhinagar

A

SUMMER INTERNSHIP PROJECT

ON

SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY

AT

WELLCARE LIFESCIENCE

Submitted To

OAKBROOK BUSINESS SCHOOL (GTU)

A Project Report Submitted in Partial Fulfillment of the requirement of the award for the degree of MBA

Under

Gujarat Technological University

Under the guidance of

Faculty Guide Company Guide

Prof. Radha Gandhi Mr. Hardik Thakkar

Submitted By

Dharmik D Bhatt

Enrollment No. 148320592002

MBA Semester III

Year 2014-16

Year 2014-16

OAKBROOK BUSINESS SCHOOL

MBA PROGRAMME

Affiliated to Gujarat Technological University, Ahmedabad

Student Declaration

DECLARATION

I undersigned DHARMIK D BHATT student of Oakbrook Business School, second Semester

hereby declare that the report for “Summer Internship Project” entitled “SWOTT ANALSIS OF

NEW PHARMACEUTICAL COMPANY” at WELLCARE LIFESCIENCE. from 2nd

June,

2015 to 27th

July, 2015 is my own work and has been carried out under the guidance of Prof.

Radha Gandhi of Oakbrook Business School, Adalaj. This has not been submitted to any other

university for any other purpose.

Date: _______________ Sign Of Student: _____________

Dharmik D Bhatt

Enroll. No. 148320592002

Place: _______________

PREFACE

Summer Internship Program is a part of Masters of Business Administration academic study,

after completion of second semester of M.B.A. We are been require undergoing for training of 6-

8 week in any reputed company/industry in order to obtain practical knowledge and enhance our

learning. It is a right time where we can gain experience and can learn new things.

This type of training makes us aware about the extent to which theoretical knowledge can be

implemented in real time environment.

For this Summer Internship Program I joined WELLCARE LIFESCIENCE pharmaceutical

company. After doing my training I lent a lot and I have prepared report which contain the company

information and about my project.

My project is on doctors and retailers & Wholesalers that how they react and percept towards the

new pharmaceutical company which means SWOT analysis of new pharmaceutical company. New

pharmaceutical companies have lots of resistance against their growth. So we must have to do

something about that resistance. There are so many small and large scale companies are there in

pharmaceutical industries. Pharmaceutical product work on directly to the human health so quality is

most important things for the all companies Trust is the biggest thing in pharmaceutical industries, so

for new companies to built a trust is typical thing. For that we must have to know the perceptions and

reactions of doctor’s retailers and wholesalers towards the new pharmaceutical company.

AKNOWLADGEMENT

Every work is not a one day task & it may require help of some or other person. In entire duration of

S.I.P there were many who helped me as and when required.

A sincere thanks to Ms. Hardik Thakkar my project guide who helped me lot throughout this project

and guide me in right direction and not only that her expertise in this topic also helped me to gain in-depth

knowledge.

I am also thankful to my project guide Prof. Radha Gandhi who always be there to provide the

information as and when required.

My sincere thanks to all the respondents including doctors, retailers and wholesalers of my survey

because without their fair response and incorporation it will be very difficult to get correct idea about

their perception and reactions towards the new pharmaceutical company.

I would like to gratitude my earnest thanks to all the faculty members of OAKBROOK BUSINESS

SCHOOL.

Finally, my heartfelt thanks to all of them who helped me directly or indirectly, knowingly or

unknowingly in this project.

“With sincere Regards”,

DHARMIK D BHATT

Date ___________

Place ___________

Executive Summary

Learning and experience which we gain by doing things practically is always different than what

we have learned through theories. We have found this opportunity with company like Wellcare

Lifescience.

Wellcare Lifescience is the company that do job work for pharmaceutical products which means

they doesn’t have production unit they purchase the finished products and label them with their

own name and sale them. Company having not much experience but they doing tremendous sale

of their products for last one and half year. They also start exporting their product and expanded

their business. I got the knowledge about the new form of business.

Pharmaceutical market is tough market to business for the new company it become more tough

because pharmaceutical products are sold on the trust of consumers. Initial level of the new

company to create the trust or the good value is the most important thing. For that we must have

knowledge about the perceptions and reactions of consumers as the first consumers for

pharmaceutical products are doctors, retailers and wholesalers. So I decided to work on topic

“SWOT analysis of new pharmaceutical company” to get the idea of market conditions for a

new company.

I have done several type of work simultaneously with my project like sales, pricing of product

making product card and visuliser.

My project is divided in to two parts, one is the perception and reactions of Doctors and second

is perception and reactions Retailers & Wholesalers towards new pharmaceutical company, And

for that I have prepared two questionnaire for both one is for doctor and another is for retailer &

wholesalers for making my survey successful.

In the end I found strength, weakness, opportunities and threat of new pharmaceutical company

and also the same of Wellcare Lifescience. Also found the perception and expectation of doctors

and retailers towards new pharmaceutical company.

INDEX

CHAPTER NO.

SUB PART

CHAPTERS Pg.No

1 Introduction of Pharmaceutical industries 1

1.1 History of Pharmaceutical Industries 2

1.2 Worldwide pharmaceutical industries 5

1.3 Top pharmaceutical Industries 9

2 Introduction of Wellcare Lifescience 10

2.1 History 11

2.2 Company Profile 12

2.3 Organization structure 13

2.4 Organization chart 13

2.5 Mission, Vision and Value of Wellcare Lifescience 13

2.6 Type of work that Wellcare Lifescience do. 14

2.7 Marketing of Wellcare Lifescience 17

2.7.1 Marketing 17

2.7.2 Market Segmentation 18

2.7.3 Pricing Decision 19

2.7.4 Advertising 20

2.7.5 Sales Promotion 20

2.7.6 Distribution Channel 21

2.7.7 International Marketing 22

2.8 Financing of Wellcare Lifescience 25

2.8.1 Financing 23

2.8.2 Financial planning 23

2.8.3 Accounting policies 23

2.8.4 Working Capital 24

2.9 Wellcare Lifescience products 25

3 Literature Review 27

4 Problem Statement 34

5 Research Topic SWOT Analysis of new Pharmaceutical Company

37

6 Research Objective 41

7 Research Methodology 43

7.1 Definition and type of research 44

7.2 Research Design 46

7.3 Sample Design 48

7.4 Research Limitation 50

7.5 Research Signification 50

8 Data analysis and interpretation 51

8.1 Doctors 52

8.2 Retailers & Wholesalers 61

9 Finding of 70

9.1 Doctor survey Data 71

9.2 Retailers & Wholesalers Survey Data 72

10 Conclusion 73

11 Suggestion And Recommendation 76

12 Bibliography and Reference 78

13 Annexure 81

Questionnaire of Doctor 82

Questionnaire of Wholesalers and Retailers 84

Products Detail 96

Wellcare Lifescience Project report

Oakbrook Business School Page 1

1

ITRODUCTION

OF

PHARMAXEUTICAL INDUSTRIES



1.1 History of Pharmaceutical Industry

Evolution of pharmaceutical Industry

In ancient India the sources of drugs were of vegetable, animal and mineral origin. They were

prepared empirically by few experienced persons. Knowledge of that medical system was

usually kept secret within a family. There were no scientific methods of standardization of

drugs

The western or the so-called Allopathic system came into India with the British traders who

later become the rulers. Under British rule this system got state patronage. At that time it was

meant for the ruling race only. Later it descended to the people and become popular by the

close of 19th century

Before 1940

Initially all the drugs were imported from Europe. Later some drugs of this system began to

be manufactured in this country

1901: Establishment of the Bengal Chemical and Pharmaceutical Works, Calcutta by

Acharya Prafulla Chandra Ray

1903: A small factory at Parel (Bombay) by Prof. T.K. Gujjar

1907: Alembic Chemical Works at Baroda by Prof. T.K. Gujjar

Drug enquiry committee

Government of India on 11th August 1930, appointed a committee under the chairmanship of

Late Col. R.N.Chopra to see into the problems of Pharmacy in India and recommend the

measures to be taken. This committee published its report in 1931. It was reported that there

was no recognized specialized profession of Pharmacy. A set of people known as

compounders were filling the gap.

Just after the publication of the report Prof. M.L.Schroff (Prof. Mahadeva Lal Schroff)

initiated pharmaceutical education at the university level in the Banaras Hindu University.



In 1935 United Province Pharmaceutical Association was established which later converted

into Indian Pharmaceutical Association.

The Indian Journal of Pharmacy was started by Prof. M.L.Schroff in 1939. All India

Pharmaceutical Congress Association was established in 1940. The Pharmaceutical

Conference held its sessions at different places to publicize Pharmacy as a whole.

1937: Government of India brought ‗Import of Drugs Bill‘; later it was withdrawn.

1940: Govt. brought ‗Drugs Bill‘ to regulate the import, manufacture, sale and distribution

of drugs in British India. This Bill was finally adopted as ‗Drugs Act of 1940‘.

1941: The first Drugs Technical Advisory Board (D.T.A.B.) under this act was constituted.

Central Drugs Laboratory was established in Calcutta

1945: ‗Drugs Rule under the Drugs Act of 1940‘ was established. The Drugs Act has been

modified from time to time and at presents the provisions of the Act cover Cosmetics and

Ayurvedic, Unani and Homeopathic medicines in some respects.

1945: Govt. brought the Pharmacy Bill to standardize the Pharmacy Education in India

1946: The Indian Pharmacopoeia List was published under the chairmanship of late

Col.R.N. Chopra. It contains lists of drugs in use in India at that time which was not included

in British Pharmacopoeia.

1948: 1985

1948: Indian Pharmacopoeia Committee was constituted under the chairmanship of late Dr.

B.N. Ghosh.

1949: Pharmacy Council of India (P.C.I.) was established under Pharmacy Act 1948.

1954: Education Regulation has come in force in some states but other states lagged behind.

1954: Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 was passed to

stop misleading advertisements (e.g. Cure all pills)



1955: Medicinal and Toilet Preparations (Excise Duties) Act 1955 was introduced to

enforce uniform duty for all states for alcohol products.

1955: First Edition of Indian Pharmacopoeia was published.

1985: Narcotic and Psychotropic Substances Act has been enacted to protect society from

the dangers of addictive drugs.

Govt. of India controls the price of drugs in India by Drugs Price Order changed from time to

time.

PHARMACOPOEIA / FORMULARIES / COMPENDIA

The books containing the standards for drugs and other related substances are known as

pharmacopoeia and formularies - collectively these books are known as the drug compendia.

The pharmacopoeias or formularies contain a list of drugs and other related substances

regarding their source, descriptions, standards, tests, formulae for preparing the same, action

and uses, doses, storage conditions etc.

These books are prepared under the authority of the Government of the respective countries.

The word ―pharmacopoeia‖ is derived from the Greek words ‗pharmacon‘ meaning ‗drug‘

and ‗poieo‘ means ‗make‘. Literally it means that it is a list of medicinal substances, crude

drugs and formulae for making preparations from them.

These books are revised from time to time so as to introduce the latest information available

as early as possible after they become established. In order to keep the size of book within

reasonable limit it becomes necessary to omit certain less frequently used drugs and

pharmaceutical adjuvant from each new edition of the book. Therefore, in each new edition

of these books certain new monographs are added while the older ones are deleted.

For the preparation of these books the expert opinion of medical practitioners, teachers and

pharmaceutical manufacturers are obtained.



1.2 Worldwide Pharmaceutical Market

The global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise

to US$400 billion within three years. The 10 largest drugs companies control over one-third

of this market, several with sales of more than US$10 billion a year and profit margins of

about 30%. Six are based in the United States and four in Europe. It is predicted that North

and South America, Europe and Japan will continue to account for a full 85% of the global

pharmaceuticals market well into the 21st century. Companies currently spend one-third of

all sales revenue on marketing their products - roughly twice what they spend on research and

development.

The pharmaceutical industry in India is the world's third-largest in terms of volume.

According to the Department of Pharmaceuticals of the Indian Ministry of Chemicals and

Fertilizers, the total turnover of India's pharmaceuticals industry between 2008 and

September 2009 was US$21.04 billion. The domestic market was worth US$12.26 billion.

The industry has a market share of $14 billion in the United States.[4]

According to the India Brand Equity Foundation, the Indian pharmaceutical market is likely

to grow at a compound annual growth rate (CAGR) of 14-17 per cent in between 2012-

16. India is now among the top five pharmaceutical emerging markets of the world.

Exports of pharmaceutical products from India increased from US$6.23 billion in 2006–07 to

$10.1bn in 2013(according to IBEF India) a combined annual growth rate of

21.25%.According to Price water house Coopers (PWC) in 2010, India joined the top 10

global pharmaceutical markets in 2020 with turnovers reaching US$50 billion.

In 2009-10, India's biopharmaceutical industry grew at 17 percent, with revenues of Rs. 137

billion ($3 billion). Bio-pharma was the biggest contributor, generating 60 percent of the

industry's growth at Rs. 88.29 billion, followed by bio-services at Rs. 26.39 billion and bio-

agriculture at Rs. 19.36 billion.

In 2013, there were 4,655 pharmaceutical manufacturing plants in India, employing over 345

thousand workers.

Today the Pharma industry is scrambling to deal with big changes that include:

https://en.wikipedia.org/wiki/United_States

https://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-4

https://en.wikipedia.org/wiki/India_Brand_Equity_Foundation

https://en.wikipedia.org/wiki/Compound_annual_growth_rate

https://en.wikipedia.org/wiki/PricewaterhouseCoopers

https://en.wikipedia.org/wiki/Biopharmaceutical



4 Trends

1. The Patent Cliff Billions in revenues will be lost due to patent expiry and the growing

competition for low-cost generics. Pharma companies are trying different strategies and

expanding their portfolios beyond prescription drugs.

2. Power Shift from Doctors towards Payers and Patients The Patent Cliff is an

opportunity for payers and patients to accelerate generic penetration, stabilize costs, reduce

price benchmarks and insist on value for money.

3. Cost-containment to Curb Healthcare Deficits Payers must find ways to contain

healthcare costs. Exerting more control over the Pharmaceutical industry is one tactic they

will use.

4. Patients are Empowered Today‘s patients know more about their diseases, choices for

medication and methods of treatment. They are taking more control of their treatment.

Implications for Pharma Companies

As Pharma works to change strategies, many companies continue to struggle with

implementation. Pharma companies must:

Improve market access -Market Access is critical to sales and survival. It requires masterful

orchestration of a complex web of activities with both internal and external stakeholders.

Find growth in new areas -There is still growth ahead for Pharma in mature and fast-

growing markets, value innovation, OTC and health nutrition, generics, diagnostics, animal

health, vaccines, orphan drugs and new drugs.

Be more productive -Pharma companies must reduce costs while improving productivity.

R&D, marketing and sales, and manufacturing and supply chains all present opportunities for

greater efficiency and productivity.

Create partnerships -Partnering with universities or smaller companies can increase

Pharma‘s portfolio while reducing development costs and sharing risk. Partnering with payers

could bring mutual benefits.

Be “patient-centric” -Putting the patient at the centre of strategy and operations, and

focusing on health outcomes rather

than medicines, distinguishes a Pharma company from rivals and creates long-lasting value.



Market Condition of Pharmaceutical Companies in India

Revenue of Indian pharmaceutical industry

The Indian pharmaceuticals market is expected to expand at a CAGR of 23.9 per cent to

reach US$ 55 billion by 2020.

Revenue share of Indian pharmaceutical sub-segments

With 72 per cent of market share (in terms of revenues), generic drugs form the largest

segment of the Indian pharmaceutical sector.



Export data of Indian pharma industry

In terms of value, exports of Indian pharmaceutical products increased at a CAGR of 26.1 per

cent to touch US$ 10.1 billion during FY06-13.

Indian pharmaceutical market segments by value

Anti-infective drugs command the largest share (16 per cent) in the Indian pharma market.



1.3 Top Pharmaceutical Companies

Worldwide top 10 Pharmaceutical Companies. In2014 on sales revenue

1 Johnson & Johnson Sales Revenue: $ 65.03 billion

2 Novartis Sales Revenue: $ 57.92 billion

3 Pfizer Inc Sales Revenue: $ 52.7 billion

4 Roche Sales Revenue: $ 50.50 billion

5 Sanofi Sales Revenue:$ 44.96 billion

6 MERCK Sales Revenue: $ 44.1 billion

7 GlaxoSmithKline Sales Revenue: $ 41.4 billion

8 AstraZeneca Sales Revenue: $ 25.7 billion

9 $Eli Lilly & Co Sales Revenue: $ 23.1 billion

10 Abbott Sales Revenue: $ 21.8 billion

India Top Pharmaceutical companies

1 Cipla Net sales = 66.86 billion INR

2 Dr Reddy‘s labs Net sales = 69.77 billion INR

3 Ranbaxy labs Net sales = 63.03 billion INR

4 Lupin Laboratories Net sales = 53.64 billion INR

5 Aurobindo Pharma Net sales = 42.84 billion INR

6 Sun pharma Net sales = 40.15 billion INR

7 Cadila Healthcare Net sales = 31.52 billion INR

8 Torrent pharma Net sales = 27.66 billion INR

9 Jubilant Life Net sales = 26.41 billion INR

10 Wockhardt Net sales = 26.5 billion INR



2

Wellcare Lifescience



2.1 History

Company was founded by Mr. Hardik thakkar. He don B. Pharmacy and MBA . Young

person Hardik having Four year experience as Medical Representative (M.R) with

multinational pharmaceutical company. He having knowledge of pharmacy field as well as

management

He started wellcare lifesceince in May 2014 with five type of different pharmaceutical

product. He was the only person at initial level of the company. He believes in quality and

service. With a good response from Ahmedabad he decides to expand his business. And he

made partnership type of company

After few months Miss Geeta Ganatra also join Wellcare Lifescience and then gradually the

increase there product mix, with good success they move to forward. At the same time ex

MD of Krushi Bank of Gujarat Mr. Harish Ganatra also join to them.

In Feb 2015 with the help of Mr.shyam Ganatra they start exporting in south Africa. With

great support of partners now they have 15 products. And they are well settle in Ahmedabad.

Moto of Wellcare Lifescience is sale medicine at the most economical rate and to get blesses

from patient.



2.2 COMPANY PROFILE

Name of company Wellcare Lifescience

Establishment year May 2014

Headquarters Navarangpura, Ahmedabad

Size of organization Small scale Company

Form of organization Partnership

Registered office 308 Abhushan Complex, Near Kalupur Bank,

Opp SVC Bank Stadium Road,

Navarangpura , Ahmedabad

E Mail I‘d [email protected]

Contact No. 07777916533

Number of Employee 5

Founder of company Mr.Hardik Thakkar

Investment 1500000

Product of company Tablets

Capsules

Suspension

Syrups

injections

Weekly Off Sunday

Banker -

Average turnover 600000 per month



2.3 Organization Structure

Organization structure means how the unit runs its business. This is a partnership firm ,so two

directors are there in Wellcare Lifescience. They set all the stretegies of business with the

support of advisory director

Whithin country they handle the all orders of Doctors, Retailers and Distributors . But for

exporting of the products they have Export Director.

2.4 Organization Chart

2.5 Mission Vision and Value of Wellcare Lifescience

Our Mission

To become a leading global pharmaceutical company with the help of satisfied customer

blesses.

Vision

―Provide highest quality of affordable healthcare for whole humankind ―

Managing Director

Hardik Thakkar & Geeta Ganatra

Advisory Director

Harish Ganatra

Supply Products to Doctors

Supply Products to Retailers

Export Director

Shyam Ganatra

Supply Products to Distributors



WellCare LifeSciences is a pharmaceutical firm started with a MASSIVE dream and a vision.

We want to be able to make the affordable healthcare accessible in every part of India and the

world.

Values

Demonstrating integrity :: We are consistent and transparent in our decisions and actions.

We fulfill our commitments and conduct ourselves in a way that is true to our identity.

Striving for excellence :: We aim to deliver the highest quality performance in everything

we do. Through creativity and innovation we continuously seek to improve our results.

2.6 Type of work that wellcare Lifescience do

Wellcare Lifescience does not have any production unit or any research center they take the

order from the market and place the order to the manufacturer.

Here the product name is of wellcare lifescinece‘s name but on the lable there ir spesification

that product is of lable with wellcare life science but manufacture by the company is printed

over their.

Wellcare Lifescience got the all products from different manufacturer and then they do

marketing of the products with own name.

On the label they print ―Marketed By Wellcare Lifescience‖ and ―Manufacture By the

Company‖. Here The manufacturer are given bellow

List of manufacturer

1 India Life Bio Science, Gandhinagar

(Gujarat)

2 Wallen Healthcare, SAS Nagar (Mohali)

3 Fedley Healthcare, Delhi

4 Athens Labs (Delhi)

5 Edwin Healthcare SAS Nagar (Mohali)

6 Gujarat Pharmaceutical, Godhara

(Gujarat)

7 Taksh Alliance Industries, Parwanoo

(Himachal Pradesh)



JOB WORk

In real business scenario, it may not be possible for an industry to carry all processes leading

to manufacture of final product within its own premises. In such an eventuality the

manufacturing unit will have to get the work done i.e. processing of the raw materials or

intermediate product from outside. The processes performed outside are called Job Work.

Definition Given By Excise

In the context of the Central Excise law, Job Work has been defined under Rule 2(n) of

the Cenvat Credit Rules, 2004 to mean processing or working upon raw material or semi-

finished goods supplied to the job worker, so as to complete a part or whole of the process

resulting in the manufacture or finishing of an article or any operation which is essential for

aforesaid process.

Looking at the above definition we can say that Job Work or Sub Contracting is an activity of

taking an order to manufacture or process goods as per the prescription of the client by

utilizing material supplied by the client or purchased on behalf of the client and charging him

for the services provided as Job Work or Sub Contract.

Job Work Flow (process) is common for industries giving/receiving job order, whether

falling under Excise or not. Job work Flow is as shown below



Reasons for the delegation of job

Job Worker has specialization in the work delegated

Time Constraint on the part of Principal to manufacture the goods

Principal does not have the facility to produce the specific semi finished goods

Difficulties in Job Work Process

Job Work OUT

Following are the problems faced when job is delegated to a Job Worker



No standard practice to delegate a Job

Monitor & Analysis of Material

Cost/Profit Tracking: Principal manufacturer can ascertain the cost of manufacture of

a job delegated. These statistics can be used to compare and analyze the cost as against cost

of manufacture of goods in house or by other Job workers.

Meeting Statutory Requirements

Job Work IN

Following are the problems faced when a Job is received by the Job worker from the

Principal Manufacturers

No standard practice for receiving a Job

Monitor & Analysis of Material Received

Job Worker Invoice

Cost/Profit Tracking: Job Worker can ascertain the cost of manufacture of a job

received. These statistics can be used to compare and analyze the cost/profit of job work

carried out for different Principal Manufacturers.

Meeting Statutory Requirement.

2.7 MARKETING OF WELLCARE LIFESCIENCE

2.7.1 Marketing

Marketing is a dynamic process. Today‘s era is basis on marketing because without

marketing any consumer will not have any information regarding your product. So, it would

be difficult for a business to sell their product without marketing.

In pharmaceutical industries marketing is somewhat tough then other industries because

pharmaceutical products are unsought products so it require to get all information about all



medical conditions , views of the doctors patients and distributor retailers , how they react

towards the pharmaceutical product because pharmaceutical product are sale under the trust

and satisfactory result only .so for pharmaceutical product marketing is most important thing

that everyone get attract with them but in ethical and legal way

―Marketing is so basic that it cannot be considered a separate function. It is the whole

business seen from the point of view of its final result, that is, from the customer‘s point of

view.‖

Marketing management has two concepts:

Traditional Marketing Approach.

Modern Marketing Approach.

―In pharmaceutical industries traditional marketing approach is not that much useful because

drugs and medicines are manufactured by the present medical conditions like which disorder

are more frequently occur according to essential drug list and time by time some drugs

produce their resistance so total study is require‖.

2.7.2 MARKET SEGMENTATION

In Pharmaceutical market segmentation is donning according to the different drugs

therapeutical use with different age and their different dose forms .according to the

geographical place there is variation in the drug dose and formulation.

There are several bases for segmentation the market which are as follows:

1 Geographical With different geographical conditions drug doses and formulations are

different

2 Demographical With different age every drug dose are different

Other two are Psychographic a behavioral both are normally not for pharmaceutical industry.

Because Pharmaceutical products are use in the medical treatment but in cosmetic products

this type of segmentations are being in use.



Pharmaceutical Market is not like B2C type of market here the doctors are the most important

part of the business. They prescribe and with the connection of retailer and distributor the

business is working.

Wellcare Lifescience having the general useable drugs which is prescribe by the doctor

frequently

NSAIDS, Antacids, protein and vitamins, anti emetic and for pregnant women type of simple

segmentation.

2.7.3 PRICING DECISION

Pricing is an important decision that every company has to take high price or low price to

create a bed prestige of the company. The price of a product is a crucial decision.

Wellcare Lifescience have some pricing strategic method that are given bellow

Cost Plus Pricing

This is the pricing method where price is set with some addition of profit with their actual

cost

Target Return Pricing

Set your price to achieve a target return-on-investment (ROI).

Going Rate Pricing

They set the price as per the sane product of other company price

Price Discrimination

They set a price of the product according to the amount of product order.

Value Pricing

For some product with high quality with high perception rate of consumer value of product is

high.



2.7.4 Advertising

Advertising is non-promotion of goods and services, by a sponsor (a firm or person) who can

be identified and who has paid for this communication. This purpose of advertisement is to

sell something a good service, idea person or place, either now or later this goal, reached by

setting specific objective that can be expressed individual ads. Those are incorporated into an

advertising campaign recall again from the buying decision process that buyers go through a

series of stages

‗Wellcare Lifescience having no specific advertisement but the connect directly to the

retailers and distributers with visualate of the products and with product card distribution

with a reference ‘.

2.7.5 SALES PROMOTION ACTIVITES

―Sales promotion is an exercise in information, persuasion and influence.‖

-William J. Stanton

Sales Promotion Strategies:

There are three types of sales promotion strategies: Push, Pull, or a combination of the two.

A push strategy involves convincing trade intermediary channel members to "push" the

product through the distribution channels to the ultimate consumer via promotions and

personal selling efforts. The company promotes the product through a reseller who in turn

promotes it to yet another reseller or the final consumer. Trade-promotion objectives are to

persuade retailers or wholesalers to carry a brand, give a brand shelf space, promote a brand

in advertising, and/or push a brand to final consumers. Typical tactics employed in push

strategy are: allowances, buy-back guarantees, free trials, contests, specialty advertising

items, discounts, displays, and premiums.



Wellcare Lifescience is usage of this above two strategies for covering the whole business

market in Ahmadabad and outside Ahmadabad

Wellcare Lifescience Providing discount on bulk purchase and also they providing some

offers to the doctors and to the retailers.

2.7.6 DISTRIBUTION CHANNELS

Distribution channels are system of economic institutions through which a producer of goods

delivers them in to the hands of their users.

Wellcare Lifescience is the company doing job work they receive the order from the market

and put the order to the manufacturer. So company initially send product to the doctors and

retailers, Here Products are used by the patient but it must be dispatch by doctor or retailer‘s

reference or preference or precessions. So The channel is fixed for all pharmaceutical

products, But There is only one change in Wellcare Lifescience distribution channel

wholesalers are not there.

Level of Channels are as under

Wellcare lifescience Doctors Patient

Wellcare Lifescience Distributor Retailers Patient

Wellcare Lifescience Retailes Patient



2.7.7 INTERNATIONAL MARKETING

International marketing means dealing and selling between two or more countries with

agreement for the product or service is called international marketing.

Wellcare Lifescience has good international marketing in South Africa around 20 % of its

sales.

COMPETITORS

It is rightly said that, ―without competitors market does not survives‖. And another thing is

that in to present market era is perfect competition. In to present marketing era competitors

are the key factor for each business. Now a day‘s consumer have alternatives so all the

company try to get more market share as compare with the another company.

Pharmaceutical market is toughest market where so many small as well as large companies

are in competition.

Small level company for new market for Wellcare Lifescience in Vadodara

Unison Manish Pharma, Unicure, Elysium, Briyosis

Large Scale Companies

Mankind, Sun Pharma, Dr.Reddy, Torrent Pharma, gsk, Intas pharma



2.8 FINANCING OF WELLCARE LIFESCIENCE

2.8.1 Financing

The finance function covers both acquisitions of funds as well as their allocation. Thus apart

from the issues involved in acquiring external funds, the main concern of finance manager is

the efficient and wise allocation of funds to various used Defined in a broad sense. It is

viewed as an integral part of overall management. To make wise decisions, a clear

understanding of the objectives are sought to be achieved, is necessary. The objectives

provide a framework for optimum financial decision-making.

2.8.2 FINANCIAL PLANNING

Financial planning means deciding in advance, the financial activities to carried on achieving

the basic goal of the company. Financial planning is top make Sure that adequate funds are

raised at the minimum cost and that used widely

―The problem of any business is not the examination of profit but the achievement of sufficient profit

to cover the risk of economic activity and thus to avoid loss.‖ -

Peter F. Drucker

There are main two types of financial planning as below mentioned:

Wellcare LifeScience belive in short term Financila planning

They set several allocation of funds and acording to that they predecide the profit margine

2.8.3 Accounting policies

The specific policies and procedures used by a company to prepare its financial statements.

These include any methods, measurement systems and procedures for presenting disclosure.



Wellcare Lifescience follows the government norms and instruction which are mentioned in

to the GAAP (Generally Accepted Accounting Principles). This company follows the all

rules and regulation of government.

2.8.4 Working capital

Working capital is the amount of funds necessary to cover the cost of operating the

enterprise. Working capital management usually concerned with the administration of this

assets viz. cash and marketable securities, receivable and inventory.

Financial Record of Wellcare Lifescience

PARTICULERS AMOUNT

Sales 6800000

Investment 3500000

Purchase Expense 10000

Opening Stock 900000

Closing Stock 400000

Selling Expense 100000

Manue & Other Expenses 90000

Current Assets 1000000

Current Liablities 500000

Capital 1500000

Fixed Asset 3000000

Secured Loan 400000

Unsecured Loan Nill

Gross Progit 1000000

Net Profit 545000



2.9 PRODUCTS OF WELLCARE LIFESCIENCE

Sr.

No

Product

Name

Product Use Product Image

1 Carecef–

200

Used to treat a wide

variety of bacterial

infections.

2 Acepar–

SP

This drug is used to treat

mild to moderate pain

and to reduce fever.

3 Ondi-

MD4

Used to treat and

prevent chemotherapy-

induced nausea and

vomiting and

radiotherapy-induced

nausea and vomiting.

4 ACIARE-

DSR

Usr in treatment of

duodenal ulcers and

erosive or ulcerative

GERD

5 ACENEC-

P

It is used for the relief of

pain and inflammation in

rheumatoid arthritis,

osteoarthritis and

ankylosing spondylitis.



6 WellVita

For

Pediatric

Used in treating or

preventing low levels of

vitamins and minerals in

the body.

7 Besty

For

Pediatric

For increasing the level of

vita B this drops are being

in use.

8 Teniwell

CV

For

Pediatric

Treatment of children

with recurrent or

persistent acute otitis

media.

9 Well-D3

For

Pediatric

Use in deficiency of Vita-

D



3

Literature Review



Reviewing the literature:

-Essential preliminary task in order to acquaint yourself with the available body of

knowledge in your area of interest.

-Literature review is integral part of entire research process and makes valuable contribution

to every operational step.

-Reviewing literature can be time-consuming, daunting and frustrating, but is also

rewarding. Its functions are:

a. Bring clarity and focus to your research problem;

b. Improve your methodology;

c. Broaden your knowledge;

d. Contextualize your findings.

For SOWT analysis of new pharmaceutical company literature are given bellow

© Kyoung Kim Yee, Lee Keun, Park Walter G and Choo Kineung found that

appropriate intellectual property protection and economic growth in countries at

different levels of development, http://www.sciencedirect.com.

It was found that patent protection is an important determinant of innovation and that

patentable innovations contribute to economic growth in developed countries, but not in

developing. Instead, in developing economies, a minor form of intellectual property rights

(IPRs). It was found that utility model innovations contribute to firm performance when firms

are technologically lagging and that those minor innovations can be a learning device and

thus a stepping stone for developing more patentable inventions later on. Thus the lesson here

is that patent protection enhances innovation and economic growth in countries where the

capacity to conduct innovative research exists. Where this capacity is weaker, a system that

provides incentives to conduct minor, incremental inventions is more conducive to growth.

The significance of this paper is to emphasize the importance not just of the strength of IPRs

but of the appropriate type of IPRs for economic development

© According to Schuiling and Moss (2004), 2013 Society of Interdisciplinary Business

Research (www.sibresearch.org)

http://www.sibresearch.org/



Pharma companies have not worked proactively in identifying a brand and identity for their

products and in communicating this identity to consumers. In particular, generic drugs in the

competition, it is extremely important for pharmaceutical companies to understand the

difference in consumer‘s perceptions and purchase intentions between branded and generic

drugs, as this understanding can help the pharmaceutical companies to better estimate the

financial impact of drug when launching a more likelihood of consumers purchasing a

branded drug, the more confident a pharmaceutical company will be in making an investment

in the branding process. Zara Ladha in 2007 studied perceived difference between generic

and branded drugs in terms of efficacy, willingness of people to pay for branded drugs and

trust of people in doctor prescribed drugs. Important factors studied were attributes like price,

name, and doctor‘s prescription, past experience, advertisement and promotion. The

conclusions were like the only influencing factor given more importance for prescription

versus non-prescription medicines Other factors like in store promotion, price,

family/friend‘s, brand name and advertising play a significant role in purchase making.

© E. Osinga from Tilburg Universityin in 2010 measure Influences of pharmaceutical

marketing on the prescribing behavior of physicians in the United States and in the

Netherlands

Partly due to high administrative costs that originate from private insurances, and increasing

costs for medical technology and prescription drugs The United States has the most

expensive health care system in the world (The U.S. health care system : Best in the world, or

just the most expensive?, 2001). This leads to the fact that many people in the United States

cannot afford health insurance. In the Netherlands health care is provided by private health

suppliers. Everybody who lives or has a job in the Netherlands is legally obliged to purchase

basic health insurance. Though, health insurance is obliged, a significant number of people is

still uninsured. Concerning pharmacist power, pharmacists are allowed to substitute a

prescribed drug in both countries. A difference is that in the United States the power of the

pharmacists is more heavily regulated. One of the major distinguishing factors when defining

both markets is that in the Netherlands direct-to-consumer advertising is not allowed. In the

United States DTCA is allowed, which brings forward increases in sales volume, yet it also

leads to the negative effect that in the United States drugs are prescribed irrationally more



often. Physician education does not differ tremendously between the Netherlands and the

United States, however in the United States the market is more transparent compared to the

Netherlands.

© Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes

and behaviors associated with DTC promotion of prescription drugs.

Pharmaceutical companies continue to increase funding for direct-to-consumer advertising.

Evidence discussed above suggests that direct-to-consumer advertising stimulates patient

demand for pharmaceuticals, may influence physician prescribing habits and likely increases

drug spending. Consumers are aware of these advertisements, and discussions about them are

becoming part of the routine provider-patient relationship. As the phenomenon of direct-to-

consumer advertising evolves and the prevalence increases, providers need to continue in

their role as advocates for patients. To do this effectively, providers should stay educated

about new medications and the evidence for their use. Providers need to understand that

patients may not have adequate information about a particular drug from advertisements,

especially risks, and that specific reinforcement of the risks of a drug is key to assuring the

patient makes an informed decision. Additionally, providers may want to prepare printed

material for patients ahead of time for some of the most heavily advertised drugs. This may

save time during the visit for other concerns and reinforce the provider‘s role as advocate

rather than create tension during a visit.

© Aditya Bhattacharjea and Fiyanshu Sindhwani. (2014) research on “Competition

Issues in the Indian Pharmaceuticals Sector “

In Pharmaceutical market there is so tough market competition so each company wants to

lead. For making ethical competition they made some laws related to that and for that laws

they set specific categories type of principle and all companies must have to follow that all

things. The maximum copy rights case we see in pharmaceutical formulation , so to make all

thing ethical with respect to original formulation all industries must have to work that they

saw in the research. Pricing is the biggest issue that they found they saw every company

having different price with same therapeutic use and with same API content so as per the

company product quality and company pricing strategy companies are came forward with the

market responds,



© Sanjiwani Jayant Kumar KJ Somaiya Studies and Research on Product and Brand

Positioning Typologies with Respect to Pharmaceutical Companies in 2013

Success of a company is dependent on successful positioning typology. Success of the

company which is measured in terms of financial performance depends on positioning

typology which majorly is Company image / reputation, product quality, efficacy, reliability

and quality of the product. Success of the company is dependent on the trust in the company.

Trust is a measurable variable and is understood as reliable company, honest company and

altruism. There is a significant difference between different positioning strategies in terms of

output expected. More competent company generates more trust in physicians mind. Trust in

the company is reflected through financial performance of the company.

© D. K. Nauriyal and Dukhabandhu Sahoo (2015 ) research on The New IPR Regime

and Indian Drug and Pharmaceutical Industry: An Empirical Analysis.

Has the new IPR regime helped the firms of the D&P industry to perform better? Yes, if the

performance is measured in terms of their sales revenue. The study confirms that even though

the R&D expenditure of the firm is less effective than the advertisement and marketing

expenditure, expenditure of the firm on this head in the long run can be more productive in

the form of more commercial patent patents and higher revenue. Furthermore, the study also

calls for more marketing and advertisement expenditure on the part of the firms to create a

‗niche market‘ for their product with ‗brand loyalty‘ among the consumer

© JSB Intelligence UK in 2005 studied on Strategic Analysis of the Pharma Market,

Future Revenue Models and Key Players “

Products are given higher priority over all approaches towards success including choice of

right partners, branding, CRM, and pricing. The new product lines are focused on modifying

disease based on NMEs, than geared towards symptoms. They will target therapeutic classes

such as cancer, infectious, female/male health, cardiovascular, metabolic, inflammatory, and

lifestyle diseases. New revenue models are favoring pharma companies despite the fall of

block busters. Pharma companies need to significantly cut down their costs, by as much as

13.5% of the revenues, and offset future loss of revenues caused by withdrawing block

busters. The winning proposition will come in the form of short and long term strategies.

Short term strategies are mainly geared towards pre- and post-patent expiry directives, and

the launch of semi block busters. Long term strategies revolve around owned health care



kiosks and consistent improvement in efficiency and cost reduction with the help of the

integrated network mode

© Li Ying in 2013 don Analysis of Marketing Strategy Plan of Pharmaceutical

Company

They found, a marketing strategy plan for Jiangxi Chenxin pharmaceutical company in the

medicinal market. The analysis of the case company helps the author realize today's situation

of the market. Internal analysis, PESTLE analysis, market analysis and SWOT analysis are

necessary to obtain a complete understanding. Through the interview and questionnaire, the

author get realizing the real situation of the case company.

The case company needs to pay more attention to customers and its brand images than it does

today. The final future marketing strategy plan should be changed based on the economic

development and the industry changes. The case company needs to change 41 the traditional

marketing strategy system that seems to be unsuitable for them to become a manufacturer. It

has changed the services at different levels, for example, different products for different

customers. The case company can use strength to maximizing brand potential. The case

company should develop products, to achieve growth, create value and obtain economies of

scale.

© by Kapil Kumar DR. M. K. Kulshreshitha in 2013 don reearchon SWOT analysis of

Indian Pharmaceutical Industries.

Pharma manufacturers are likely to benefit from rise in demand for generic products. Some of

the factors that would drive growth in the domestic pharma industry are: 1) low cost

operations 2) research-based processes 3) improvements in API and 4) availability of skilled

manpower. The domestic formulations and bulk drugs markets are currently facing price

pressure as benefits of cheaper drugs have been shifted to end-users and trade channels.

Hence, consolidation, partnership and alliances are expected to gather momentum in the near

future. Off patenting of branded drugs would increase demand for generic drugs. This

provides immense opportunities to the Indian pharmaceutical companies especially given

their prior experience in generic drug development. Some other factors such as high

penetration in the global markets and increase of share in Abbreviated New Drug Application

(ANDA) filings are likely to power growth of the formulations market. Major growth drivers

for the Indian bulk drug industry include rise in demand for contract manufacturing, increase



of share in Drug Master Files (DMF) filings and process innovation. Furthermore, initiatives

of the Government will act as a backbone for growth. Some such initiatives include: 1)

allowing 100% FDI under the automatic route in drugs and pharmaceuticals including those

involving use of recombinant technology 2) increasing weighted tax deduction on

expenditure in in-house R&D activities to 200% in the Budget 2010 and 3) setting up a US$

639.56 mn venture capital fund to support drug discovery and strengthen pharmaceutical

infrastructure.



4

Problem Statement



THE RESEARCH PROCESS AND FORMULATION OF RESEARCH

PROBLEM

The research process is similar to undertaking a journey.

For a research journey there are two basic thing I kept in my mind which are the question and

how I have to solve it?

1 Research is on the basis of what kind of things helpful for the new pharmaceutical company

and which are the things that push back to the bottom to a new pharmaceutical company

Which kind of things are there in doctors and in retailers mind for new pharmaceutical

company?

Which kind of market that Vadodara have for new pharmaceutical company?

mWhat is their perception towards new pharmaceutical company?

2 We have to know which are the strength and weakness, which are the opportunity and

threats are there for new pharmaceutical company. It means we have to find the external and

internal attributes which helpful and harmful for the company.

Formulating Problem Statement

So many pharmaceutical companies are there in Indian Market so for a new pharmaceutical

company cannot set themselves in the market, for that we have to find the way through which

the company can make a strategy and set them self in less time

Which kind of work they have to do to increase their strength and how they reduce their

weakness.

New pharmaceutical company having several problems like-

1 Doctors generally not prefer a new pharmaceutical company products .they think that it

may have quality problem, it may have service problem it may have price problem.

2 Retailers never wish to store new pharmaceutical company problem because customers and

doctor having less trust on the new company



3 New Company having no previous experience so no one wants to take risk for the

medicinal therapy

4 Everyone have wrong perceptions about new companies have problem with their reliability

service quality etc

5 Because of giant competition and numbers of companies are available so customers have

more choices.

From This we can say that we have to know about new pharmaceutical company Strength

that separate the company from other, we have to work on our weakness, we have to find the

way or opportunity that new company can lead, also looking for the threat in pharmaceutical

industry

So in short we have to do The SWOT Analysis of New pharmaceutical Company



5

RESEARH TOPIC

SWOT ANALYSIS

OF

NEW PHARMACEUTICAL COMPANY

SWOT ANALYSIS



Albert Humphrey was an American business and management consultant.

During his work at the Stanford Research Institute (1960 – 1970), he produced a team method

for planning which was named SOFT analysis, this has developed into what we now know as

a SWOT analysis. SWOT is worth noting that you should set the final objective after

completing the SWOT analysis. The reason for this is to ensure that the objectives are

achievable and not unrealistic given the current internal and external environments.

Each organization or business has to deal with both internal and external factors that affect

them.

Users of the SWOT analysis can therefore use the first two sections (Strengths and

Weaknesses) to help them identify all of the internal factors. The last two sections

(Opportunities and Threats) will be used to identify all of the external factors.

When determining each of the sections it is really important that the right questions are asked.

A SWOT analysis that does not produce or help towards producing realistic and achievable

goals is useless. Have a look at the ―sample‖ questions that you could ask for each section.

These are just a short selection and will differ from objective to objective and from

organization to organization. The important point to take away is that the right question will

help to produce a really valuable SWOT analysis.



Strengths(Internal factor / Positive influence)

What are we best at?

What intellectual property do we own that can help us with this objective?

What specific skills does the current workforce have that can contribute to this

objective?

What financial resources do we have for reaching this objective?

What connections and alliances do we have?

What is our bargaining power with both suppliers and intermediaries?

Opportunities (External factor / Positive influence)

What changes in the external environment can we exploit?

What weaknesses in our competitors can we use to our advantage?

What new technology might become available to us?

What new markets might be opening to us?



Weaknesses (Internal factor / Negative influence)

What are we worst at doing?

Is our intellectual property outdated?

What training does our workforce lack?

What is our financial position?

What connections and alliances should we have, but don‘t?

Threats (External factors / Negative influence)

What might our competitors be able to do to hurt us?

What new legislation might damage our interests?

What social changes might threaten us?

How will the economic cycle affect us?

As mentioned before, the above list is not comprehensive. You can also turn a threat into an

opportunity or something that is a weakness today might be turned into a strength with some

effort.

The SWOT analysis is taught to students in the Certificate in Professional Marketing and is

used in the Marketing module together with a PEST or PESTEL analysis to produce a

comprehensive audit of the internal and external environment for an organization which they

will take into the exam.

http://www.professionalacademy.com/cim-marketing-courses/certificate-in-professional-marketing



6

Research Objective



The formulation of objectives:

-Objectives are the goals you set out to attain in your study.

-They inform a reader what you want to attain through the study.

-It is extremely important to word them clearly and specifically.

Objectives should be listed under two headings:

a) main objectives ( aims);

b) sub-objectives.

Main Objective

To find the Strength, weakness, Opportunities and threat of the company and all new

pharmaceutical companies.

To find out the perception and expectation of doctors and retailers towards the new

pharmaceutical company.

Sub Objectives

To find out the big player of the market (Tough Competitor).

To find the way for new pharmaceutical company from tough competition.

To create strategy for company with the help of research detail.

To analyze Vadodara market for company.

To create good communication bridge between new company to doctors and retailers, that

fulfill all require expectation of both.



7

RESEARCH METHODOLOGY

FOR

RESEARCH TOPIC

“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”



7.1 Definition And Types Research

Research is undertaken within most professions.

It is a habit of questioning what you do, and a systematic examination of the observed

information to find answers with a view to instituting appropriate changes for a more

effective professional service.

DEFINITION OF RESEARCH

The word research is composed of two syllables, re and search. Re is a prefix meaning again,

anew or over again search is a verb meaning to examine closely and carefully, to test and try,

or to probe. Together they form a noun describing a careful, systematic, patient study and

investigation in some field of knowledge, undertaken to establish facts or principles.

Research is a structured enquiry that utilizes acceptable scientific methodology to solve

problems and create new knowledge that is generally applicable. Scientific methods consist

of systematic observation, classification and interpretation of data.

―Our research is on pharmaceutical industries that how new company can expand business in

tough competition which are the harmful and helpful things‖

TYPES OF RESEARCH

Research can be classified from three perspectives:

1. Application of research study

2. Objectives in undertaking the research

3. Inquiry mode employed

Application:

From the point of view of application, there are two broad categories of research:

- Pure research and

- Applied research.



―SWOT analysis is one type of applied research where we have to find out the Strength,

Weakness, opportunities and Threat via knowing the doctors and retailer perceptions and

reactions towards new pharmaceutical company‖.

Objectives:

From the viewpoint of objectives, a research can be classified as

- Descriptive - Co relational

- Explanatory - Exploratory

―From the SWOT analysis we can know what are the real problem that face new

pharmaceutical company and get the bulk information about the market condition for new

pharmaceutical company so my research is descriptive type of research ―.

Inquiry Mode:

From the process adopted to find answer to research questions – the two approaches are:

- Structured approach

- Unstructured approach

Main objective is to describe the variation in a phenomenon, situation or attitude.

―Here in my research I have to know perceptions and reactions it means I have to know the

attitude of doctors and retailers so my research is of unstructured type of research‖.



7.2 PREPARING THE RESEARCH DESIGN

Research design is the conceptual structure within which research would be conducted.

The function of research design is to provide for the collection of relevant information with

minimal expenditure of effort, time and money.

The preparation of research design, appropriate for a particular research problem, involves

the consideration of the following:

1. Objectives of the research study.

2. Method of Data Collection to be adopted

3. Source of information—Sample Design

4. Tool for Data collection

5. Data Analysis-- qualitative and quantitative

Objectives of the Research Study

With respect to the objective our research study is on ―Doctors & Retailers and Wholesalers‖

Major and Sub objective are there in topic 6 Research objective.

Methods of Data Collection:

There are two types of data

Primary Data: collected for the first time

Secondary Data: those which have already been collected and analyzed by someone else.

―Here for the research I used primary and secondary both data collection‖

Methods for Primary Data Collection

OBSERVATION METHOD:

Commonly used in behavioral sciences

It is the gathering of primary data by investigator‘s own direct observation of relevant People,

actions and situations without asking from the respondent.



EXPERIMENTAL METHOD

Also called Empirical Research or Cause and Effect Method, it is a data-based research,

coming up with conclusions which are capable of being verified with observation or

experiment.

Experimental research is appropriate when proof is sought that certain variables affect other

variables in some way.

I use Survey method for my research

SURVEY METHOD

Approach most suited for gathering descriptive information.

Structured Surveys: use formal lists of questions asked of all respondents in the same way.

Unstructured Surveys: let the interviewer probe respondents and guide the interview

according to their answers.

For my research I prepare one questionnaire as per my research objective so my is

―structured survey‖.

Survey research may be Direct or Indirect.

Direct Approach:

Would you like to use new pharmaceutical company product?

Indirect Approach:

Do you have experience with new pharmaceutical company? How was that?

From the response, the researcher may be able to discover why the consumer avoids

―I used both type of research question in my questionnaire in structured survey‖

Secondary data are collected from books, from official websites, literatures etc.

CONTACT METHODS:

Information may be collected by

Mail

Telephone

Personal interview



―I used Personal Interview for my questionnaire‖

Personal Interviewing:

It is very flexible and can be used to collect large amounts of information. Trained

interviewers are can hold the respondent‘s attention and are available to clarify difficult

questions. They can guide interviews, explore issues, and probe as the situation requires.

Personal interview can be used in any type of questionnaire and can be conducted fairly

quickly.Interviewers can also show actual products, advertisements, packages and observe

and record their reactions and behavior.

This takes two forms-

Individual- Intercept interviewing

Group - Focus Group Interviewing

―I personally meet to all the doctors and retailers & wholesalers and take the answer from

them‖.

―Here For my research I prepared two questionnaires one is for doctors and another one is for

retailers & wholesalers. Both questionnaires are seemlier in nature just a difference is in some

questions and with some behaviors‖.

7.3 DETERMINING SAMPLE DESIGN

Researchers usually draw conclusions about large groups by taking a sample.A Sample is a

segment of the population selected to represent the population as a whole. Ideally, the sample

should be representative and allow the researcher to make accurate estimates of the thoughts

and behavior of the larger population.

Designing the sample

1 The Sample- Doctors and Retailers & wholesalers

2 Sample Size- Total 100 Sample

Doctors – 60

Retailers & Wholesalers – 40



3 Sampling

―I used probability and non probability sampling both‖.

Non Random Sampling for Doctors

Quota sample - MBBS, Specialist (Eye, Ear, Nose) Neurologist, Orthopedic, Pediatric,

Dentists

Random Sampling

Simple random sampling - All different type of doctors are sample out randomly

―All retailers & Wholesalers are sample out according to the particular doctor connection and

within doctors rang‖.

Tool for Data Collection (Research instrument)

The construction of a research instrument or tool for data collection is the most important

aspect of a research project because anything you say by way of findings or conclusions is

based upon the type of information you collect, and the data you collect is entirely dependent

upon the questions that you ask of your respondents. The famous saying about computers-

―garbage in garbage out‖- is also applicable for data collection. The research tool provides

the input into a study and therefore the quality and validity of the output (the findings), are

solely dependent on it.

The Questionnaire:

Structured surveys/ interviews employ the use of a questionnaire.

A questionnaire consists of a set of questions presented to a respondent for answers. The

respondents read the questions, interpret what is expected and then write down the answers

themselves.

There are three basic types of questionnaire:

• Closed –ended

• Open-ended

• Combination of both

In my Both Questionnaires I used all three type of question

In Doctors questionnaire – 8 Questions out of them 1 open ended, 6 close ended and 1

combination of both.



In Retailers & Wholesalers – 7 questions out of them 1 open ended, 5 close ended and 1

combination of both.

7.4 Research Limitation

From the entire population research is only on 60 doctors and 40 Retailers with

wholesalers which is less sample size.

Here in our research target audience is only of Vadodara‘s doctors retailers and

wholesalers, there may variation in result with other cities.

Research is basically don with some perception of the both the hand means of

researcher and target audience both.

Respondent‘s reluctance to answer questions asked by unknown interviewers about

things they consider private. Busy people may not want to take the time.

May try to help by giving pleasant answers

May answer in order to look smart or well informed.

7.5 Research Signification

Marketing and operation Strategy creation become easy with the help of research

data.

We can get the perception and expectation of the doctors and retailers from New


We can get the helpful and harmful attribute for new pharmaceutical company in

India.

To know Pharmaceutical market of Vadodara.

We can get the previous experience of new pharmaceutical company from doctor and

Retailers.

We can catch the biggest threat creator player of market.



8.1

ANALYSIS

AMD

INTERPRETATION

OF

DOCTOR SURVEY DATA



1 Do you prefer to use (Prescribe or dispense) a new pharmaceutical company

products?

Yes ⃝ No ⃝

Result Percentage

Yes 33 55

NO 27 45

60 100

Interpretation

From the graph we can say easily that the 55 percent doctors are ready to prescribe or

dispense new pharmaceutical products in Vadodara. There is a chance to success in Vadodara

if they sale their product in Vadodara. So there is good opportunity to do business for new


55

45

Percentage %

Yes

NO



2 If you have any experience with new pharmaceutical products, then how was it?

Excellent ⃝ Very Good ⃝ Good ⃝ Average ⃝ Bad ⃝ Very Bad ⃝ Poor ⃝

Result Percentage

Excellent 0 0

Very Good 3 5

Good 20 33.333333

Average 27 45

Bad 7 11.666667

Very Bad 3 5

Poor 0 0

60 100

Interpretation

In Vadodara doctors having average experience with new pharmaceutical company product.

We can say that doctors will prefer to use a new pharmaceutical company product. So new

pharmaceutical company having a opportunity to set themselves.

0

10

20

30

40

50

Percentage %

Percentage



3 What do you like most?

Prescribing ⃝ Dispensing ⃝

Result Percentage

Prescribing 54 90

Dispensing 6 10

Interpretation

From the above graph maximum doctor prefer to prescribe. So new pharmaceutical company

have target customers are Retailers and Wholesalers.

So for the new pharmaceutical company has to make strategy towards retailers more, so with

the recommendation of doctor and support of retailer new pharmaceutical company is

working.

Condition is like doctors recommendation and retailers attraction base business will succeed

for new pharmaceutical company.

90

10

Percentage %

Prescribing

Dispensing



4 What would make you prescribe a new Company over the well settle company for

pharmaceutical products?

Economic to doctor Economic to patient

Higher Quality Better service

Other: - ______________________

Result Percentage

Economic to Doctor 7 11.666667

Economic to Patient 51 85

Higher Quality 36 60

Better Service 21 35

Other 2 3.3333333

Interpretation

From the above graph result, it shows that to prescribe a new company product over the well

settle company the product must be economic to the patient and with good quality is require.

So there is an opportunity for new company, if new pharmaceutical company product is

economic to patient and good in quality then they can set their business more quickly.

So company with good quality will definitely make there image in market.

11.66666667

85 60

35

3.333333333

Percentage %

Economic to Doctor

Economic to Patient

Higher Quality

Better Service

Other



5 What is your perception towards new pharmaceutical company?

Quality Issues Service Issues Reliability Issues

Availability Issues Price Issues

Percentage Result

Quality Issue 70 42

Service Issue 50 30

Reliability Issue 70 42

Availability Issue 51.66667 31

Price Issue 23.33333 14

All 13.33333 8

Interpretation

From the above graph can say that , new pharmaceutical company having several issues from

that all availability and reliability issue are the most, some of doctor also suffer with all the

issues also.

So new pharmaceutical company having biggest weaknesses are availability and reliability

issues are generated.

If new company work on it , so they can take it as opportunities also.

0 20 40 60 80

Quality Issue

Service Issue

Reliability Issue

Availability Issue

Price Issue

All

Percentage %

Percentage



6 Which is the first thing you see in a product with a new Pharmaceutical company?

Quality & Commitment ⃝ Price ⃝

Service & Regularity ⃝ Packaging ⃝

% Percentage Result

Quality & Commitment 51.67 31

Service & Regularity 11.67 7

Price 31.67 19

Packaging 5 3

100 60

Interpretation

From the above analysis, it shows 51.67 percentage of doctors looking for quality and

commitment when new pharmaceutical company product came in market.

So it indicates that with good quality and with comfortable price doctor will defiantly go with

new pharmaceutical company product.

51.67

11.67

31.67

5

Percentage

Quality & Commitment

Service & Regularity

Price

Packaging



7 As per your point of view rank the new company features. (1-6)

Availability & Service Product Mix Patient satisfaction

Good Quality Packaging Type Comfortable price

Rank Result

1 2 3 4 5 6

Availability & Service

16 6 13 13 4 8 60

Good Quality 21 20 10 4 2 3 60

Product Mix 4 4 5 14 23 10 60

Packaging Type 0 2 2 6 25 25 60

Patient Satisfaction 16 18 16 8 2 0 60

Comfortable Price 3 10 14 15 4 14 60

60 60 60 60 60 60

Rank Result in Percentage

1 2 3 4 5 6


26.67 10 21.67 21.67 6.67 13.33 100

Good Quality 35 33.33 16.67 6.67 3.33 5 100

Product Mix 6.67 6.67 8.33 23.33 38.33 16.67 100

Packaging Type 0 3.33 3.33 10 41.67 41.67 100

Patient Satisfaction 26.67 30 26.67 13.33 3.33 0 100

Comfortable Price 5 16.67 23.33 25 6.67 23.33 100

100 100 100 100 100 100

0

5

10

15

20

25

30

1 2 3 4 5 6


Good Quality

Product Mix

Packaging Type

Patient Satisfaction

Comfortable Price



Interpretation

From the above analysis the priority of doctors shows the first priority is good quality for

pharmaceutical product and last priority is to Packaging type.

It shows 1 to 6 rank order priority of doctors

Average rank order of priority characteristic of pharmaceutical company to doctor is

Rank

1 Good Quality

2 Patient Satisfaction

3 Availability & Service

4 Comfortable Price

5 Product Mix

6 Packaging Type

From this we can set priority of work which is hundred percentage work is require but by at

the some extant which come first or which things are more accurate.

0

10

20

30

40

50

1 2 3 4 5 6


Good Quality

Product Mix

Packaging Type


Comfortable Price



8 Give your special suggestion for new pharmaceutical company?

Some of the acceptable suggestion are given bellow that help to the new pharmaceutical

company to set themselves in most successive way…

1 Quality work is under the GMP and ISO but regularity and service is depends on company

itself. Focus on Service.

2 R&D work push company growth more quickly. Existing are there but do something

innovative.

3 Do complete market analysis and implement your strategy according to the most ethical

way.

4 Do qualitative work and get the all certification of that and maintain it for a long time.

5 Do the ethical work and get profit out of it.

6 Do not produce same molecule products, make some combinatory molecule that help to

patient and doctor both.

7 Packaging is most important thing, show creativity in packaging.



8.2

ANALYSIS

AMD

INTERPRETATION

OF

Retailer & Wholesaler Survey Data



1 Would you like to try working with a new pharmaceutical Company?

Yes ⃝ No ⃝

Answer % Percentage

Yes 29 72.5

No 11 27.5

40 100

Interpretation

From the graph we can easily say that retailers and wholesalers like to work with new


So as per the survey it indicate that new pharmaceutical company having good opportunity to

set themselves in this positive looking market, where consumers are ready to join.

72.5

27.5

Percentage

Yes

No



2 Which is the first thing you see in a product with a new pharmaceutical company?

API Content ⃝ Price ⃝ Availability ⃝

Therapeutic use ⃝ Packaging ⃝

Result % Percentage

API Content 12 30

Price 10 25

Availability 8 20

Therapeutic Use 7 17.5

Packaging 3 7.5

40 100

Interpretation

From the graph its shows that everything is more or less equal so everything is the first look

of product by the retailers but the most viewer look for the API content that product have is

the first thing when the new pharmaceutical company product in retailers hand.

So from the result we can say new company has to work on all then and only then new

company make there image well in market.

30

25 20

17.5

7.5

Percentage

API Content

Price

Availability

Therapeutical Use

Packaging



3 What would make you prefer a new Company over the well settle company for

pharmaceutical products?

Competitive rates Packaging type

Higher Quality Availability & Service

% Percentage Result

Competitive Rates 52.25 19

Packaging Type 22 8

Higher Quality 35.75 13

Availability & Service 57.75 21

Interpretation

From graph result it clearly shows that to compete the well settle pharmaceutical company

new pharmaceutical company have to focus on competitive rate and availability & Service.

This shows the clear way to satisfy the retailer and wholesalers requirement.

Percentage

Competitive Rates

Packaging Type

Higher Quality




4 What dissatisfy you with current Pharmaceutical company products?

Price Availability & Service

Packaging Type Quality

% Percentage Result

Price 52.5 21

Packaging type 10 4

Availability & Service 40 16

Quality 20 8

Interpretation

Its shows the current market is cover with the high price . Most of the retailers are dissatisfy

with the price from current pharmaceutical company products.

So we can say that with comfortable price of products retailer will defiantly attract with new


52.5

10

40

20

Percentag

Price

Packaging type


Quality



5 Which companies Pharmaceutical Products you store in bigger quantity?

Exemed pharma Elysium Unicure

Manish Pharma Briyosis Sarabhai Pharmaceutical

Other: - _______________

Company Name Result Percentage

Exmed Pharma 3 7.5

Elysium 4 10

unicure 17 42.5

Briyosis 2 5

Sarabhai 17 42.5

Manish Pharma 8 20

Unison 28 70

Other 6 15

Interpretation

From the result there are so many competitors but the biggest market is of Unison


This graph shows that the newly enter pharmaceutical companies has the toughest competitor

name Unison pharma

So it indicate that new company has to make strategy with put center to the unison company

as target.

7.5 10

42.5

5 42.5 20

70

15

Percentage Exmed PharmaElysiumunicureBriyosisSarabhaiManish PharmaUnicureOther



So from the graph the biggest threat maker is unison pharmaceutical for new company in

Vadodara.

6 As per the point of view rank the new company features. (1-6)



Rank Result

1 2 3 4 5 6

Availability & Service 10 4 9 8 4 5 40

Good Quality 10 17 5 3 2 3 40

Product Mix 4 6 2 10 8 10 40

Packaging Type 0 3 4 1 17 15 40

Patient Satisfaction 11 8 11 5 4 1 40

Comfortable Price 5 2 9 13 5 6 40

40 40 40 40 40 40

Rank Result in Percentage

1 2 3 4 5 6

Availability & Service 25 10 22.5 20 10 12.5 100

Good Quality 25 42.5 12.5 7.5 5 5 100

Product Mix 10 15 5 25 20 16.66667 100

Packaging Type 0 7.5 10 2.5 42.5 25 100

Patient Satisfaction 27.5 20 27.5 12.5 10 1.666667 100

Comfortable Price 12.5 5 22.5 32.5 12.5 10 100

100 100 100 100 100 100

0

5

10

15

20

1 2 3 4 5 6


Good Quality

Product Mix

Packaging Type


Comfortable Price



Interpretation

This is the priority rank order for the medicinal system characteristics by the retailers and

wholesalers .

For retailers and wholesalers first thing fort take care is to satisfy the patients with the good

quality with the heist ratting.

All characteristics are most important but with the rank order product mix is not most

important thing for retailer that Packaging type is rated at the last 6th

position

Average Rank order priority of Retailers and wholesaler is given bellow

Rank

1 Good Quality



3 Comfortable Price

5 Product Mix

6 Packaging Type

0

10

20

30

40

50

1 2 3 4 5 6


Good Quality

Product Mix

Packaging Type


Comfortable Price




Some of the acceptable suggestions are given bellow that help to the new pharmaceutical

company to set themselves in most successive way…

1 Pricing is the biggest issue for the all company so do pricing with respect to Patient as well

as Retailer also.

2 Patient satisfaction is the most important thing so never compromise with the quality.

3 Make some product with specific characteristics that only your product has which lead you

automatically in to the market.

4 Always be specific with your distribution channel and give the complete service.

5 Do not offer the schemes but give the comfortable price that all can afford.

6 Decrease our lead time with quick respond.

7 Attracting to the patient advertisement is require so do some advertisement.

8 Make packaging attractive and tough.

9 Printing of the strip price , content, MFG and EXP date in bigger font size that make easy

to read.



9

Finding



Apart from the main topic ―SWOT analysis of new pharmaceutical company‖ the main thing

is to increase the sales of the company from getting the outer environment of pharmaceutical

market for new company. Wellcare Lifescience is a new company. They wants to expand

their business so they need such kind of information that we found.

From The survey I found several things that are given bellow

FOR DOCTORS

55 % of doctors are ready to make a relationship with ne pharmaceutical company.

Doctors having 33% good and 45% average experience with new pharmaceutical

company.

90% doctor likes prescribing.

With higher quality of product and product with greater patient satisfaction doctors

prefer a new company over the well settle pharmaceutical company.

70% of doctors having perception that new pharmaceutical company has always

issues with there quality and reliability.

Quality and commitment is the first thing that doctors wants to see with a new

pharmaceutical company product.

Average rank order of priority characteristic of pharmaceutical company to doctor is

Rank

1 Good Quality


3 Comfortable Price

4 Product Mix

5 Packaging Type




FOR RETAILERS & WHOLESALERS

72.5% retailers and wholesalers are ready to make relation with new pharmaceutical

company.

API Content is the first thing for the retailers and wholesalers to see when new

pharmaceutical company product is in their hand.

With a competitive rate and service retailer and wholesalers would make them to

prefer a new company over the well settle pharmaceutical company

52.5% Retailers and wholesalers are dissatisfy with there prices that companies are

offering to him.

With 40% of all retailers and wholesaler are also dissatisfy with the availability &

service.

With 70% of retailers having unison pharma company product stock is in bigger

quantity.

Average Rank order priority of Retailers and wholesaler is given bellow

Rank


2 Good Quality


3 Comfortable Price

5 Packaging Type

6 Product Mix

Perceptions that we found from the survey are-

Quality and Reliability issues are maximum with new pharmaceutical company.

Expectations that we found from survey are-

Quality product with Competitive rate and better service are the expectation of there.



10

CONCLUSION



Every companies have there own strategies to make them self different from other. Final goal

of every company is to earn maximum profit out of there investment, here with this survey I

got several things are generated from which help company to make strategies and get

something out of it.

With better quality competitive rate and advance service new pharmaceutical company can

set themselves in market with great response.

In Vadodara there is good enough market for new pharmaceutical company to their business.

From the research of primary and secondary data that we collected

“SWOT analysis of new pharmaceutical company”



Wellcare Lifescience Company SWOT analysis from the research



12

SUGGESTIONS

AND

RECOMMENDATIONS



From the survey I knew some important things that improve company sales and value which

are the biggest asset of the company. All organizations believe in more profit and it must be

ethical and social way of business, so proper suggestions opinions and recommendations are

require.

For increasing the sales and expanding the business every one‘s support is require for that

several things which help to improve the business are given bellow –

Pricing is the biggest issue in pharmaceutical industries so according to the patient

overall conditions or with respect to the overall country economic status of people

M.R,P Should be there on the products. Which help to improve the value of the

company and it make affordable price to the patient so increase sales also.

With the innovative drug formulations and combinations which help the doctors and

retailers to dispense and that make patient happy.

Pharmaceutical sector is on the human‘s life so as per demand and shortage it must be

available in the market so new company should work on there availability and on

reliability that makes positive marks towards the new company.

Storage and handling is also one of the biggest issue for the users so the packaging

must be tough and attractive to the patient as well as for doctors and retailers also.

As per the retailers recommendation they want the bigger font size print on the strip

and on the label. That makes comfortable visualize print.

For increasing sale company should tray with arraigning free camp for patient with

doctors. Means doing promotions for the company products.

Now a days user are attracting more towards the advertisement promotions and

internet or online help center so company can go with this kind of tools that increase

user‘s awareness towards the company.



12

Bibliography

And

Reference



Books

Naval Bajpai, (2012). 1st Edition. Research Methodology, Dorling Kindersley (India) Pvt.

Ltd.

Philip Kotler (2014). 15th Edition. Marketing Management, Dorling Kindersley (India) Pvt.

Ltd.

Ken Black(2009). 5th Edition. Business Statistics, Wiley India Pvt. Ltd.(India) . (Calculation

of hypothesis)

Reference

Kyoung Kim Yee, Lee Keun, Park Walter G and Choo Kineung found thatappropriate

intellectual property protection and economic growth in countries at different levels of

development,

According to Schuiling and Moss (2004), 2013 Society of Interdisciplinary Business

Research

E. Osinga from Tilburg Universityin in 2010 measure Influences of pharmaceutical

marketing on the prescribing behavior of physicians in the United States and in the

Netherlands

Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and

behaviors associated with DTC promotion of prescription drugs.

Aditya Bhattacharjea and Fiyanshu Sindhwani. (2014) research on“Competition Issues in the Indian

Pharmaceuticals Sector “

Sanjiwani Jayant Kumar KJ Somaiya Studies and Research on Product and Brand Positioning

Typologies with Respect to Pharmaceutical Companies in 2013

D. K. Nauriyal and Dukhabandhu Sahoo (2015 ) research on The New IPR Regime and Indian Drug

and Pharmaceutical Industry: An Empirical Analysis.

JSB Intelligence UK in 2005 studied on Strategic Analysis of the Pharma Market, Future Revenue

Models and Key Players ―

Li Ying in 2013 don Analysis of Marketing Strategy Plan of Pharmaceutical Company

Kapil Kumar DR. M. K. Kulshreshitha in 2013 don reearchon SWOT analysis of Indian

Pharmaceutical Industries.



JOURNAL TITLES:

Pharmacy management

Pharmacy Times

Pharmacy Today

Websites

http://www.wellcareworld.com/wp/

http://www.drugs.com

http://www.ibef.org/industry/pharmaceutical-india/showcase

http://www.forbes.com/sites/liyanchen/2015/06/04/2015-global-2000-the-worlds-largest-

drug-and-biotech-companies/

http://www.newagepublishers.com/samplechapter/000896.pdf

http://www.ihmgwalior.net/pdf/research_methodology.pdf

http://www.medicinenet,com

http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1

http://www.wellcareworld.com/wp/

http://www.drugs.com/

http://www.ibef.org/industry/pharmaceutical-india/showcase

http://www.forbes.com/sites/liyanchen/2015/06/04/2015-global-2000-the-worlds-largest-drug-and-biotech-companies/

http://www.forbes.com/sites/liyanchen/2015/06/04/2015-global-2000-the-worlds-largest-drug-and-biotech-companies/

http://www.newagepublishers.com/samplechapter/000896.pdf

http://www.ihmgwalior.net/pdf/research_methodology.pdf

http://www.medicinenet,com/

http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1



13

Annexure

Questionnaire for Doctors and Retailer & Wholesalers



SWOT Analysis of New Pharmaceutical Company

Questionnaire for Doctor

1 Do you prefer to use (Prescribe or dispense) a new pharmaceutical company products?

Yes ⃝ No ⃝

2 If you have any experience with new pharmaceutical products, then how was it?

Excellent ⃝ Very Good ⃝ Good ⃝ Average ⃝ Bad ⃝ Very Bad ⃝ Poor ⃝

3 What do you like most?

Prescribing ⃝ Dispensing ⃝

4 What would make you prescribe a new Company over the well settle company for pharmaceutical

products?

Economic to doctor Economic to patient

Higher Quality Better service

Other: - ______________________

5 What is your perception towards new pharmaceutical company?

Quality Issues Service Issues Reliability Issues Availability Issues Price Issues

6 Which is the first thing you see in a product with a new Pharmaceutical company?

Quality & Commitment ⃝ Price ⃝

Service & Regularity ⃝ Packaging ⃝





_________________________________________________________________________________

_________________________________________________________________________________

_________________________________________________________________________________



PERSONAL DETAILS

NAME : _________________________________________________________________

Occupation : ____________________ since _______

Would you like to make relation with “WELLCARE LIFESCIENCE”? Yes ⃝ No ⃝

Contact No. :____________________ E Mail:__________________________________

Thank you for your Precious time!!!



SWOT Analysis of New Pharmaceutical Company

Questionnaire for Wholesaler & retailer

1 Would you like to try working with a new pharmaceutical Company?

Yes ⃝ No ⃝

2 Which is the first thing you see in a product with a new pharmaceutical company?

API Content ⃝ Price ⃝ Availability ⃝

Therapeutic use ⃝ Packaging ⃝

3 What would make you prefer a new Company over the well settle company for pharmaceutical products?

Competitive rates Packaging type

Higher Quality Availability & Service

4 What dissatisfy you with current Pharmaceutical company products?

Price Availability & Service

Packaging Type Quality

5 Which companies Pharmaceutical Products you store in bigger quantity?

Exemed pharma Elysium Unicure

Manish Pharma Briyosis sarabhai Pharmaceutical

Other: - _______________





_________________________________________________________________________________

_________________________________________________________________________________

_________________________________________________________________________________



PERSONAL DETAILS

NAME :_________________________________________________________________

Occupation :____________________ Since _______

Would you like to make relation with “WELLCARE LIFESCIENCE”? Yes ⃝ No ⃝

Contact No. :____________________ E Mail:__________________________________

Thank you for your Precious time!!!



Wellcare Lifescience Product Detail

Carecef – 200

Category – Antibiotic

API Contebt

Cafixime dispersible

Therapeutic use

Used to treat a wide variety of bacterial infections. This medication is known as a

cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats

only bacterial infections

Cefixime treats infections of the:

Ear: Otitis caused by Haemophilus influenza, Moraxella catarrhalis and Streptococcus

pyogenes.

Sinuses: Sinusitis.

Throat: Tonsillitis, pharyngitis caused by Streptococcus progenies.

Chest and lungs: Bronchitis, pneumonia caused by Streptococcus pneumonia and

Haemophilus influenza

It is also used to treat typhoid fever



HOW TO USE

Take this medication by mouth with or without food as directed by your doctor, usually

once a day. In children, this medication may also be taken twice a day (every 12 hours)

It is on the World Health Organization's List of Essential Medicines, a list of the most

important medication needed in a basic health system.

Acepar – SP

Category - NSAID

API Content

Aceclofenac, paracetomol and serratiopeptidase

Therapeutical Use

Aceclofenac

It is used for the relief of pain and inflammation in rheumatoid arthritis, osteoarthritis and

ankylosing spondylitis

Paracetamol

This drug is used to treat mild to moderate pain (from headaches, menstrual periods,

toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever

Serratiopeptidase



It is proteolytic enzyme that has potent anti-inflammatory property

HOW TO USE

Oral tablet as directed by doctor.

Ondi- MD4

Category- Serotonin 5-HT3receptor antagonist

API Content

Ondansetron

Therapeutic Use

Used to treat and prevent chemotherapy-induced nausea and vomiting and radiotherapy-

induced nausea and vomiting.

Used off-label to treat morning sickness and hyperemesis gravidarum of pregnancy. It is

typically used after trials of other drugs have failed.

Antiemetic agents used during the vomiting phase of cyclic vomiting syndrome.

Used to reduce vomiting associated with gastroenteritis and dehydration.



How to Use

To prevent nausea from chemotherapy, take this medication by mouth usually within 30

minutes before treatment begins.

ACIARE-DSR

CATEGORY- Anti Ulcer

API Content

Rabeprazole Sodium

Domperidone

Therapeutic Use

Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or

ulcerative GERD;

Maintaining healing and reducing relapse rates of heartburn symptoms in patients with

erosive or ulcerative GERD;

treatment of daytime and nighttime heartburn and other symptoms associated with GERD;

Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison

syndrome; in combination with amoxicillin and clarithromycin to eradicate Helicobacter

pylori in patients with H. pylori infection and duodenal ulcer disease.

How to use



Oral Doses form take as directed by doctors.

ACENEC-P

Category - NSAID

API Content

Aceclofenac

Paracetamol

Therapeutic Use

It is used for the relief of pain and inflammation in rheumatoid arthritis, osteoarthritis and

ankylosing spondylitis.

( It should not be given to people with porphyria or breast-feeding mothers, and is not

recommended for children.)

How to use

This is oral doses form. Use as directed by the doctor.



WellVita

Category – Multivitamin

Composition

Vitamin A, Vitamin C Carbohydrates, Fat, Diary Fibers, Zinc, Folic Acid, Sucrose, Iodine,

Sucrose, Protein, Colecalciferol, Thiamine Hydrochloride, Riboflavin Sodium Phosphate,

Niacin amide, Cynocobalamine, D Pentanol, Manganess, Molybdenum, Selenium, L Lysine

Use

Used in treating or preventing low levels of vitamins and minerals in the body. It may also be

used for other conditions as determined by your doctor.

Multivitamin drops are a vitamin and mineral supplement. It works by providing extra

vitamins and minerals to the body when you do not get enough from your diet.

How to Use

Syrup is for pediatric use only, as per the doctors suggestion accurate drops are

administered orally to the child.



Besty

Category Nutrient

API Content

D Fructose

Choline Chloride

And Carbohydrates, Sucrose, Dietary Fibers, Protein

Therapeutic use

Here all are the normal nutrients but special content of the product is combination of d

fructose and choline chloride. Choline chloride is part of vita B .so for increasing the level of

vita B this drops are being in use.

How to use

It is a pediatric oral drops. As directed by doctors.



Teniwell CV

Category – Antibiotic

API Content

Amoxiciline

Potassium Clavulanate

Therapeutic Use

Treatment of children with recurrent or persistent acute otitis media due to S. pneumoniae ,

Haemophilus influenzae , or Moraxella catarrhalis characterized by antibiotic exposure for

acute otitis media within the preceding 3 months and who are either 2 yr of age or younger

or attend day care.

How to use

Anti biotic oral suspension for only children. Dose as directed by doctor.



Well-D3

Category

API Contents

Cholecalciferol

And Carbohydrates, Sucrose, Dietary Fibers, Protein

Therapeutic use

Cholecalciferol is known as Vita D3

Vitamin D3 is a fat soluble vitamin which is important for maintaining normal bones and

teeth due to its key role in calcium metabolism and bone function.

The most effective form of vitamin D is vitamin D3 or cholecalciferol. In recent years, there

has been growing evidence that vitamin D may play a role in the prevention of serious

chronic diseases.

Vitamin D is produced naturally when the skin is exposed to direct sunlight. However,

people living in northerly latitudes, people who do not get enough sunlight or people who

wear sunscreen do not typically make enough vitamin D. Also, newborn infants are not

naturally exposed to direct sunlight and breast milk is typically low in vitamin D.

How To use

Well D3 Is Pediatric use only. Dose is as per doctors suggestion.

merged_document_6

Documents